These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1168 related items for PubMed ID: 18922683

  • 1. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis.
    Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z.
    J Dermatol Sci; 2009 Jan; 53(1):48-54. PubMed ID: 18922683
    [Abstract] [Full Text] [Related]

  • 2. Olopatadine hydrochloride improves dermatitis score and inhibits scratch behavior in NC/Nga mice.
    Murota H, El-latif MA, Tamura T, Amano T, Katayama I.
    Int Arch Allergy Immunol; 2010 Jan; 153(2):121-32. PubMed ID: 20407268
    [Abstract] [Full Text] [Related]

  • 3. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis.
    Tominaga M, Tengara S, Kamo A, Ogawa H, Takamori K.
    J Dermatol Sci; 2009 Jul; 55(1):40-6. PubMed ID: 19443185
    [Abstract] [Full Text] [Related]

  • 4. Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis.
    Schulte-Herbrüggen O, Fölster-Holst R, von Elstermann M, Augustin M, Hellweg R.
    Int Arch Allergy Immunol; 2007 Jul; 144(3):211-6. PubMed ID: 17579279
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous scratching behaviour in DS-Nh mice as a possible model for pruritus in atopic dermatitis.
    Yoshioka T, Hikita I, Asakawa M, Hirasawa T, Deguchi M, Matsutani T, Oku H, Horikawa T, Arimura A.
    Immunology; 2006 Jul; 118(3):293-301. PubMed ID: 16827890
    [Abstract] [Full Text] [Related]

  • 6. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
    Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, Matsushima K, Tamaki K.
    J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
    [Abstract] [Full Text] [Related]

  • 7. Effects of tacrolimus ointment on the expression of substance P, nerve growth factor, and neurotrophin-3 in atopic dermatitis.
    Kim HO, Lee CH, Ahn HK, Park CW.
    Int J Dermatol; 2009 Apr; 48(4):431-8. PubMed ID: 19335435
    [Abstract] [Full Text] [Related]

  • 8. Synergetic effects of prednisolone and olopatadine on atopic dermatitis model of hairless mice.
    Kagawa Y, Izawa K, Yano H, Kamei C.
    Pharmacology; 2010 Apr; 85(5):286-94. PubMed ID: 20453552
    [Abstract] [Full Text] [Related]

  • 9. Content of vascular endothelial growth factor in stratum corneum well correlates to local severity of acute inflammation in patients with atopic dermatitis.
    Amarbayasgalan T, Takahashi H, Dekio I, Morita E.
    Int Arch Allergy Immunol; 2012 Apr; 157(3):251-8. PubMed ID: 22042099
    [Abstract] [Full Text] [Related]

  • 10. Effect of an antiallergic drug (Olopatadine hydrochloride) on TARC/CCL17 and MDC/CCL22 production by PBMCs from patients with atopic dermatitis.
    Furukawa H, Takahashi M, Nakamura K, Kaneko F.
    J Dermatol Sci; 2004 Dec; 36(3):165-72. PubMed ID: 15541638
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice.
    Jiang J, Yamaguchi T, Funakushi N, Kuhara T, Fan PS, Ueki R, Suto H, Kase Y, Ikeda S, Ogawa H.
    J Dermatol Sci; 2009 Oct; 56(1):37-42. PubMed ID: 19647983
    [Abstract] [Full Text] [Related]

  • 13. Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
    Hon KL, Lam MC, Leung TF, Wong KY, Chow CM, Fok TF, Ng PC.
    Int J Dermatol; 2007 Dec; 46(12):1258-62. PubMed ID: 18173519
    [Abstract] [Full Text] [Related]

  • 14. Serum mast cell tryptase is not a useful marker for disease severity in psoriasis or atopic dermatitis.
    Gerdes S, Kurrat W, Mrowietz U.
    Br J Dermatol; 2009 Apr; 160(4):736-40. PubMed ID: 19076976
    [Abstract] [Full Text] [Related]

  • 15. Severity of disease, rather than xerosis, correlates with pruritus in patients with atopic dermatitis.
    Hachisuka J, Takeuchi S, Kido M, Fukiwake N, Furue M.
    Int J Dermatol; 2009 Apr; 48(4):374-8. PubMed ID: 19335422
    [Abstract] [Full Text] [Related]

  • 16. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study.
    Dou YC, Hagströmer L, Emtestam L, Johansson O.
    Arch Dermatol Res; 2006 Jun; 298(1):31-7. PubMed ID: 16586073
    [Abstract] [Full Text] [Related]

  • 17. Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis.
    Raap U, Werfel T, Goltz C, Deneka N, Langer K, Bruder M, Kapp A, Schmid-Ott G, Wedi B.
    Allergy; 2006 Dec; 61(12):1416-8. PubMed ID: 17073871
    [Abstract] [Full Text] [Related]

  • 18. Severity scores, itch scores and plasma substance P levels in atopic dermatitis treated with standard topical therapy with oral olopatadine hydrochloride.
    Hosokawa C, Takeuchi S, Furue M.
    J Dermatol; 2009 Apr; 36(4):185-90. PubMed ID: 19348655
    [Abstract] [Full Text] [Related]

  • 19. Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model.
    Takano N, Sakurai T, Ohashi Y, Kurachi M.
    Br J Dermatol; 2007 Feb; 156(2):241-6. PubMed ID: 17223862
    [Abstract] [Full Text] [Related]

  • 20. The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice.
    Tamura T, Amano T, Ohmori K, Manabe H.
    Eur J Pharmacol; 2005 Nov 07; 524(1-3):149-54. PubMed ID: 16259975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.